
Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
Keywords: فاکتور نکروز تومور; Ulcerative Colitis; Crohn's Disease; Treatment; Safety; Pregnancy; ADA; adalimumab; BCG; bacillus Calmette-Guérin; CZP; certolizumab pegol; ELISA; enzyme-linked immunosorbent assay; IBD; inflammatory bowel disease; IFX; infliximab; Ig; immunoglobulin;